20+ Leading OTC Event 17+

Transcription

1 IBC LIFE SCIENCES 6-9 March 2017, Mandarin Orchard Hotel, Region s Leading OTC Event New Speakers and Refreshed Agenda Case Studies A Stellar Speaker Line Up Including Gabriel Perera Director of Business Development and Product Development, Asia Blackmores, Debjit Rudra Area Vice President and General Manager South East Asia GSK Consumer Healthcare Zhao Libin Global Regulatory Affairs Associate Director Tasly, China Richa Goswami APAC Head of Digital Johnson and Johnson Glenn Sung Regional Regulatory Director, APAC, MEA & LATAM Mundipharma Consumer Healthcare, Andreas Setiawan Santoso Head of CRM and Digital Division PT Kalbe Farma Indonesia Selcuk Koksal Sales Director for and Brunei Reckitt Benckiser Ruch De Silva Commercial Director & Team Leader, Value Brands Takeda WHAT S NEW IN 2017? Plus! Pre and Post Conference Strategic Workshops Industry Leaders Dialogue: The New Self-Medication Journey and Implications for the OTC Drug Industry: Hear from multistakeholders perspectives GSK insights on R&D and Drug Innovation What is Open Innovation and its relevance to Consumer Healthcare in Procter and Gamble PRE-CONFERENCE WORKSHOPS Bayer s perspectives on pharmacovigilance and risk minimisation for new OTC drugs Country-focused Updates: Hear from Procter & Gamble India, Merck Philippines, PT Kalbe Farma Indonesia, and Great Eastern Drug Company Thailand Develop and Optimise a Cross-Functional Switch Team Pharma Panel on regional business development opportunities The Novartis approach to Rx-OTC switch strategy Produced by Johnson & Johnson Case Study on meeting digital transformation in consumer healthcare Rx to OTC Switch Keeping Pace with Strategic Aspects of Commercial and Technology Trends POST-CONFERENCE WORKSHOPS Retail and Marketing of OTC Drugs Online Licensing Agreements and Strategic Partnerships in Asia Media Partners International Marketing Partner

2 CONFERENCE DAY 1 Tuesday 7th March Registration and Morning Coffee 0845 Welcome from IBC Asia & Ice Breaker 0900 Chairperson s Opening Remarks MARKET TRENDS 0910 Consumer Healthcare in Asia: Where is it Heading? Asia s OTC and Consumer Healthcare market outlook Global OTC trends and its impact on Asia Categories with potential growth and player dynamics Growing importance of consumer and market insights on Marketing and Innovation strategies Trends influencing the future of OTC pharma market: disruptive technology, Debjit Rudra, Area Vice President and General Manager, South East Asia, GSK Consumer Healthcare 0940 Updates on the Evolving Asia Pacific OTC Regulatory Climate Overview of the regulatory updates in Asia Progress for ASEAN Regulatory Harmonization and impact to consumer healthcare Trends of regulatory changes within region and country level Dr Noppadon Adjimatera, Regional Regulatory and Medical Affairs Director, Reckitt Benckiser, Thailand 1010 The New Self-Medication Journey and Implications for the OTC Drug Industry Meeting the growing demand of increasing confident consumers on selfmedication and ageing population Highlighting commercial aspects of R&D and technology trends in OTC manufacturing The impact of technology and monitoring devices on consumer healthcare Changing landscape of retail and distribution The growing role of digital and its increasing use by tech-savy consumers How do we deal with growing disruptive trends in healthcare? PANELISTS Debjit Rudra, Area Vice President and General Manager, South East Asia, GSK Consumer Healthcare, Nissim Ghoge, Regional Brand Director Asia, Middle East, Africa, Novartis Alcon, Ryan O Donnell, Head of Digital, OTC, APAC, Johnson & Johnson, INDUSTRY LEADERS DIALOGUE 1050 Morning Tea 1120 Building OTC Brands and Portfolio Strategy in the Region Addressing the challenges of brandbuilding in Asia Takeda s unique approach to portfolio strategy and product diversification Case Study 1: Successful launch of OTC product in Country A Case Study 2: Needs-based product launch in Country B Ruch De Silva, Commercial Director and Team Leader, Value Brands, Takeda, 1150 Establishing Digital Transformation in the OTC market Uncovering opportunities and addressing potential challenges What are the barriers to change? Optimizing new touch points with empowered, digitally savvy customers what s the best way to engage? How to gain buy-in from key stakeholders to drive transformation and innovation Measuring ROI of marketing activities on digital platforms Richa Goswami, APAC Head of Digital, Johnson and Johnson, 1220 Market Analysis for OTC Segments and Growth Opportunities Growth Drivers in Asia Assessing the strategic impact of ASEAN Economic Community and Trans-Pacific Partnership on OTC markets in Asia Understanding changing consumer buying behavior and category purchase dynamics Identifying new trends and opportunities Evolution of distribution and consumer engagement Harnessing disruptive technologies in OTC market 1240 Networking Lunch Joint Interactive Roundtable Discussions Roundtable 1: VMS Market in Asia Commercial, Regulatory and Market Potential Roundtable 2: Analgesics Market How are We Capitalising Analgesics Fast Moving Market? Are Product Innovations Good Enough? Roundtable 3: Rx to OTC Switch Future Commercial Prospects and Progress PRODUCT DEVELOPMENT AND PARTNERSHIPS 1350 Conceptualization to Commercialization of Health Supplements Driving organic business growth through strategic product development Formulation design and new drug delivery format and ingredients Regulatory strategies for health supplement approvals Gabriel Perera, Director of Business Development and Product Development, Asia, Blackmores, 1420 R&D Role in Product Innovation and Life Cycle Management Harnessing insights for consumer relevant innovation and determining key markets Key considerations for robust formulation chaise suitable for multiple manufacturing platforms Role of clinical research and consumer validation in the development of consumer relevant claims Considerations for creation of a design space for critical formulation and process parameters relevant for regulatory registration and technical transfer Product roll out and defense: post-launch support Narendra Vutla, R&D Director International, GSK, India 1450 Production Innovation: New Drug Delivery Format and Packaging Innovation Creative study designs and the use of state-of-the-art technology Innovation claims in line with regulatory and medical requirements Innovative packaging and delivery format to encapsulate different population profile 1520 Afternoon Tea 1550 Capitalising on VMS Growth in Asia to Accelerate Cerebos Business Defining key business drivers Identifying source of volume Consumer and shopping centric innovation Case study on a brand re-launch Sylvain Bonnet Garcia, Head of Category & Marketing for Health Supplements Asia, Cerebos Pacific Limited, 1620 Portfolio Management and Branding Strategy for Rx to OTC Switches Examining the Rx to OTC Switch prospects Ensuring the continued support from medical professionals and doctors Optimising Rx to OTC switch process from marketing and commercial perspectives What factors are reshaping the OTC drugs market Nissim Ghoge, Regional Brand Director Asia, Middle East, Africa, Novartis Alcon, 1650 Creating and Implementing Innovative Regulatory Strategies Regulatory Affairs: a key strategic partner in development plans Out-of-the-box thinking on building relations with health authorities and cross-departmental functions What makes a successful switch in Asia Glenn Sung, Regional Regulatory Director, APAC, MEA & LATAM, Mundipharma Consumer Healthcare, 1720 Pharmacovigilance and Risk Minimization for New OTC Drugs Overview of safety regulatory requirements for OTC products in Asia Ensuring safe and accurate labelling for OTC products in Asia Risk minimization and safety monitoring of OTC products Current practices and future perspectives Jean-Christophe Delumeau, Head of Pharmacovigilance China and Asia-Pacific, Bayer (South East Asia), 1750 Chairperson s Summary and End of Conference Day 1

3 CONFERENCE DAY 2 Wednesday 8th March Chairperson s Opening Remarks COUNTRY-FOCUSED UPDATES 0910 Regulatory Strategies for TCM Products and China OTC Market Outlook Brief outlook of current China OTC Market Regulatory strategies and pathways on gaining approvals for TCM OTC product in Asia, EU and USA Key considerations on the development of herbal safety, efficacy and quality Case Study 1: Herbal Rx to OTC switches (China) Case Study 2: TCM OTC Marketing Authorization in the EU Zhao Libin, Global Regulatory Affairs Associate Director, Tasly, China 0940 Philippines: Driving Consumer- Centric Marketing Strategies Leveraging on consumer and market insights in formulating marketing strategies Marketing with consideration of target audience (Consumers and Healthcare Professionals) Case Study: Success factors for the firstever Merck s Direct-to-Consumer launch of Neurobion from Rx-Switch Debbie Go, Head of Marketing, Consumer Healthcare, Merck Inc, Philippines 1010 Thailand: Game Changers and Agility in Thailand s Mature OTC Segment Thailand OTC Market Overview trends, challenges and opportunities Is OTC extinct: adapting to a changing consumer behavior and needs Exploring market expansion and accessibility growth in a mature OTC segment Revolution or Evolution: Operational Agility in 2020 Rhett Hemedes, Head, OTC Marketing, Great Eastern Drug Co Ltd, Thailand 1040 Morning Tea THE FUTURE OF RETAIL AND DISTRIBUTION 1110 Market Entry Opportunities for OTC Drug Business Development in the Region OTC license agreements: a current Asia perspective Market entry consideration in the context of: - Marketing and Commercializing - Research alliances - Rx to OTC switches - Regulatory PANELISTS Rhett Hemedes, Head, OTC Marketing, Great Eastern Drug Co Ltd, Thailand Zhao Libin, Global Regulatory Affairs Associate Director, Tasly, China Debbie Go, Head of Marketing, Consumer Healthcare, Merck Inc, Philippines PANEL DISCUSSION 1140 Distributor s Value Add in OTC Market: Ensuring Easy Access and Deeper Outreach to Consumers in Asia Market expansion strategies Omni-channel management 1210 Networking Lunch 1310 E-revolution: From Carts to Clicks How has it worked for VMS products and its future trends Considerations to put products on ecommerce Dealing with regulations (if any) Implementing ecommerce channel sales strategies Case Study: Broad Overview of Blackmores China ecommerce Success Wong Wai Loon, ecommerce Manager for Asia, Blackmores, 1340 Retailers Perspective: Physical Retail Pharmacy VS Online Retail Pharmacy Future Outlook and Potential How have consumer needs shifted? Potential growth categories of OTC products User-friendliness of OTC products clarity of dosage and usage instruction, drug facts label How to improve on retail store categorization and shopper experience Watsons Online Retail Store: learnings, challenges and success factors Tan Seow Hwei, Cluster Pharmacy Manager, Watsons, 1410 Building OTC Commercial Strategies Product Innovation and Brand Activation Consumer engagement strategies through retail pharmacy stores In-store execution of strategies Selcuk Koksal, Sales Director for and Brunei, Reckitt Benckiser, 1440 Local Partnerships for Expanding Your OTC Drugs Footprint yvonne.leong@ibcasia.com.sg 1510 Afternoon Tea EXPLORING NEW BUSINESS MODELS: BEYOND-THE-PILL 1540 Open Innovation and New Business Creations What is Open Innovation and its relevance to Consumer Healthcare Organizational enablers and barriers for Open Innovation Integrating Open Innovation concept with other functions such as Manufacturing, Marketing, Operations How Open Innovation enables creation and execution of (New) Business Strategy Siva Muthukrisnan, Head of Open Innovation and New Business Creation, Procter and Gamble, India 1610 Consumer-Driven Marketing and Innovation Strategies Consumers as active drivers of business Leveraging on consumer and market insights Driving commercial innovation How to shift from what you do and what you offer to how you offer and how you engage Abhijit Ghone, Senior Marketing Manager, Asia-Pacific, Johnson and Johnson, 1640 The Journey to Engaging Consumers the Kalbe way! Evaluating the changing profile of consumers Online engagement of consumers and post-purchase service Success stories on CRM strategy implementation in nutrition and pharma sectors Andreas Setiawan Santoso, Head of CRM and Digital Division, PT Kalbe Farma, Indonesia 1710 Driving Inorganic Growth in OTC Market: M & A and Collaboration Strategies What drives M&A and partnerships between consumer health companies What are the M&A / partnering strategies and cross-implications for global, regional, local and emerging companies? Are consumer health deal valuations stretched? What is driving valuation levels? Future M&A landscape Viren Mahurkar, Regional Director, Business Development & Licensing Asia & Russia, Novartis Alcon, 1740 Chairperson s Summary and Close of Conference

4 PRE-CONFERENCE WORKSHOPS Monday 6th March am 12.00pm Workshop 1: Rx to OTC Switch Keeping Pace with Strategic Aspects of Commercial and Technology Trends Drug manufacturers, regulators and consumers are increasing pressure on pharma companies to make the Rx to OTC switch, as non-prescription medications are cheaper and easier to access. While the OTC market is fragmented and increasingly competitive, Rx to OTC switches continue to lie at the heart of growth in the OTC drugs market. Join us as we discover: What technology is trending? How are manufacturing adapting to the changes? How are these changing the business models? How are regulatory outlook in key markets? What are the economic and financial impact of recent Rx-to-OTC switches? At the workshop, we will: Understand the dynamics of technology and upcoming commercial development in Rx to OTC switches Prioritising key features to increase likelihood of successful switch Strategies to market and brand your Rx to OTC switch products Explore out-of-the-box ways to cultivate the right relationship with the stakeholders Find out how is Rx to OTC switches are changing business models Glenn Sung Regional Regulatory Director, APAC, MEA & LATAM, Mundipharma Consumer Healthcare, Glenn has extensive strategic leadership experience in the regulatory environment with over 27 years in OTC, has been complimented by in degrees in Pharmacy, Hospital Pharmacy and Drug Development Science that has assisted in understanding the science thereby achieving successful outcomes with health authorities and developing teams. Possess track record of success in building innovative business regulatory/marketing strategies together with constructive regulatory options to meet brand sales and profit target for Asia Pacific pm 4.00pm Workshop 2: Develop and Optimise a Cross-Functional Switch Team As Rx to OTC movement continue to remain relevant, the transition often poses a challenge to the pharma industry. In order to capitalize on what the good OTCs can offer, it is critical for cross-functional switch team to work closely in a structured way to optimize and ensure profitability of the switch processes. For workshop leader opportunity, please contact: ariel.tan@ibcasia.com.sg Key topics to discuss: Firming up the basics of switch process Understanding the future of Rx to OTC Switches influence of technology, advancement, proper life cycle management How to full own your brands: anti-counterfeit product strategies Best practices updates for building an Rx to OTC switch program POST-CONFERENCE WORKSHOPS Thursday 9th March am 12.00pm Workshop 3: Retail and Marketing of OTC Drugs Online OTC Goes Online: E-commerce in pharmaceuticals will accelerate soon and become an important distribution channel for the sector as it develops. As conditions of the sector mature, coupled with increasingly tech-savvy consumers, e-commerce may have a significant impact on the entire pharmaceutical industry chain in years to come. Is Asia ready to ride on the wave? Join us as we find out: How are online platforms affecting the way people shop How do you optimize online sales through e-commerce channel? What are the challenges that you can anticipate? How to deliver excellent execution strategies Leading long-term sales development: Understanding ecommerce channel and strategies to improve sales and profitability Mike Anthony Founder and CEO engage Ltd, Thailand Mike is founder and CEO of engage. A pioneer in consumer goods marketing, Mike Anthony is a passionate practitioner, speaker, and trainer who has helped countless businesses discover new opportunities and achieve better brand returns. After a consumer goods career spanning 17 years and three continents, Mike redirected his energy and enthusiasm toward founding engage, a global management consultancy that leverages the power of a unique vision of shopper marketing and customer management to deliver better brand returns pm pm Workshop 4: Licensing Agreement and Strategic Partnerships in Asia The global OTC drugs market will continue to be largely driven by demographics, economic trends and changes in cultural attitudes towards self-medication. Besides increasing interest in self-medication, M&A activities will remain very active in the coming years fueled by strategic long-term commercial priorities as companies continue to explore opportunities to expand OTC portfolios. The workshop will cover: What are some growth challenges faced by companies in this space? How relevant are M&A and collaboration strategies in current context? Are these viable alternatives to Product Innovation and typical organic growth strategies? How do small and medium-sized players fit in the matrix? What are the main considerations? Future direction of M&A and Cross-Sector Collaboration Nilesh Wadhwa Independent Life Sciences Consultant Nilesh Wadhwa is a Life Sciences Executive with over 20 years of rounded experience within Pharmaceuticals (incl. Generics), Nutritionals, OTC /Consumer Healthcare and Biotechnology. During his career, he has worked with multinationals such as Solvay Pharmaceuticals, Banner Pharmacaps Inc, Sanofi (Asia Pacific) and more recently as Head of Business Development and Strategy at Takeda Pharmaceuticals Asia Pacific. He has been actively involved in forging a series of alliances and has led many licensing and merger & acquisition projects. He was also instrumental in developing the strategic roadmap for Sanofi s expansion in generics and consumer healthcare within Asia and developed an operational plan for expanding Sanofi s presence in these segments.

5 IBC LIFE SCIENCES 6-9 March 2017, Mandarin Orchard Hotel The OTC pharma and consumer healthcare products markets in Asia offer continued avenues for growth. Coupled with increasing health and wellness awareness and new trends in selfmedication, Asia s OTC market is expected to continue growing in the years to come. Over the two days, the 7th Annual OTC Pharma Asia will explore the hottest trends in self-medication, partnerships for market penetration, new trends in regional markets and last but not the least, commercial strategies to help improve your OTC category bottom line. With SIX successful series in a row and positive reviews from the attendees this year, IBC s OTC Pharma Asia is returning in 6-9 March 2017,. 7th Annual OTC Pharma Asia is bringing new speakers and key experts in OTC and VMS markets to address pertinent issues in Asia the changing consumer buying behavior, technology and consumer-centric marketing as well as product innovation strategies. This unique platform in Asia center staging top leaders in OTC drugs, global pharma manufacturers, retailers, FMCGs, government and regulatory bodies and pharmacies to highlight winning strategies in Asia through practical insights and case studies. WHAT PAST ATTENDEES SAID: Insightful with knowledgeable speakers. A good mix of industry peers and service providers unlike other meetings I ve attended! Informative 2-days meeting. Pleased to connect with people in different fields from different OTC pharma companies. Very good event with many examples from various categories. Regional Regulatory and Medical Affairs Director, Reckitt Benckiser Senior Product and Innovation Manager, Mundipharma Senior Medical Manager, Pfizer WHO WILL YOU MEET? BY INDUSTRY BY COUNTRY Pharma Companies... 50% Health Suppliment Companies... 15% CROs... 10% FMCG... 10% Distributors... 10% Others (Consultants, Packaging and Labelling and software providers)...5% /Malaysia... 55% Other Southeast Asia countries... 20% North Asia & India... 15% US/Europe & ANZ... 10% SPONSORSHIP SOLUTIONS CAN BE TAILORED TO YOUR NEEDS! To position your company as a market leader at this event, and to explore the range of thought leadership, speaking, branding and marketing opportunities available. Please Contact: Yvonne Leong